Table 2.
Antimicrobial resistance profiles of the Romanian and UK canine Staphylococcus spp. isolates.
| Antibiotic | MSSP | P | MRSP | P | CoNS | P | |||
|---|---|---|---|---|---|---|---|---|---|
| Romania 49 (55.1) | UK 40 (54.9) | Romania 7 (27) | UK 19 (73) | Romania 29 (56.9) | UK 22 (43.1) | ||||
| β-lactams | |||||||||
| Oxacillin | 0 (0) | 0 (0) | – | 6 (85.7) | 16 (84.2) | 0.99 | 13 (44.8) | 14 (63.6) | 0.29 |
| Cefovecin | 0 (0) | 1 (2.5) | – | 1 (14.3) | 9 (47.4) | 0.19 | 6 (20.7) | 9 (40.9) | 0.21 |
| Cefalexin | 0 (0) | 1 (2.5) | – | 2 (28.6) | 11 (57.9) | 0.38 | 5 (17.2) | 10 (45.5) | 0.06 |
| Amoxicillin-clavulanic acid | 0 (0) | 2 (10) | 0.08 | 1 (14.3) | 9 (47.4) | 0.2 | 2 (6.9) | 9 (90) | <0.001 |
| Non β-lactams | |||||||||
| Clindamycin | 17 (34.7) | 5 (12.5) | 0.03 | 7 (100) | 13 (68.4) | 0.15 | 7 (24.1) | 8 (36.4) | 0.52 |
| Trimethoprim-sulphamethoxazole | 8 (16.3) | 2 (5) | 0.18 | 5 (71.4) | 13 (68.4) | 0.99 | 1 (3.5) | 6 (27.3) | 0.03 |
| Gentamicin | 9 (18.4) | 2 (5) | 0.10 | 5 (71.4) | 8 (42.1) | 0.38 | 1 (3.5) | 8 (36.4) | 0.03 |
| Tetracycline | 29 (59.2) | 12 (30) | 0.01 | 7 (100) | 8 (72.7) | 0.24 | 17 (58.6) | 9 (40.9) | 0.33 |
| Chloramphenicol | 15 (30.6) | 0 (0) | 0.003 | 1 (14.3) | 6 (31.6) | 0.62 | 3 (10.3) | 0 (0) | 0.55 |
| Enrofloxacin | 0 (0) | 0 (0) | – | 2 (28.6) | 10 (52.6) | 0.4 | 5 (17.2) | 4 (40) | 0.2 |
| Fusidic acid | 20 (40.8) | 18 (45) | 0.86 | 1 (14.3) | 11 (100) | <0.001 | 12 (41.4) | 14 (63.6) | 0.19 |
| MDR | 16 (32.7) | 3 (7.5) | 0.004 | 7 (100) | 18 (94.7) | 0.99 | 10 (34.5) | 12 (54.6) | 0.25 |
The data is presented as number (percentage) of isolates exhibiting resistance to each tested antimicrobial. P-values are from either Fisher's exact test or Chi-Square test for count data.
MSSP, methicillin susceptible Staphylococcus pseudintermedius; MRSP, methicillin-resistant Staphylococcus pseudintermedius; CoNS, coagulase-negative staphylococci; MDR, multidrug resistant.